Sponsored Links

BRIEF-Takeda gets European conditional marketing authorization for Adcetris

Related Topics

LONDON | Wed Oct 31, 2012 5:03am EDT

LONDON Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd : * Millennium and Takeda announce European conditional marketing authorization

for adcetris (brentuximab vedotin) * Millenium - Takeda intends to launch adcetris across Europe, with the first

launches planned in the coming weeks
Healthcare
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.